About IMAGENOMIX CORP.
Imagenomix provides AI-powered cancer diagnostics and pathology services, enhancing trial enrollment and access to targeted therapy through fast, affordable, and accurate AI recognition software. The company addresses global challenges in molecular cancer testing and precision medicine.
Mutation prediction and sample adequacy analysesCustom AI model developmentAI-powered image analysis of whole slide imagesData analysis of clinical trial, biobank, and electronic health records dataPredictive modeling for disease prognosis, treatment response, and drug efficacyConsulting and telepathology services
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to IMAGENOMIX CORP. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.